Sort
39,280 grants matching “leukemia”
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
$336,150Joel L Pomerantz · Johns Hopkins University · R01 · FY2017 · CA
Microenvironment-Leukemia Communication Through Lectins
$336,150Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2016 · CA
Transposon Insertion Polymorphisms in Predispositions to Hematopoietic Neoplasia
$336,150Kathleen H Burns · Johns Hopkins University · R01 · FY2017 · CA
Epigenetic Regulation of Germ Cell Differentiation from a Stem Cell Lineage
$336,147Xin Chen · Johns Hopkins University · R01 · FY2012 · HD
Genomics of Familial MDS/AML
$336,142Timothy A Graubert · Washington University · P01 · FY2015 · CA
Novel Myeloid Cell Transforming Properties of Interleukin-27 Receptor
$336,129Gary W Reuther · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Novel Myeloid Cell Transforming Properties of Interleukin-27 Receptor
$336,129Gary W Reuther · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Understanding T Cell Rapamycin Resistance
$336,118Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Combination Gene Therapy and Th1Th2 Therapy
$336,118Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
$336,114Jianjun Chen · University Of Cincinnati · R01 · FY2017 · CA
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
$336,114Jianjun Chen · University Of Cincinnati · R01 · FY2016 · CA
TUMOR PROMOTER MACROPHAGE DIFFERENTIATION AND APOPTOSIS
$336,092University Of Chicago · R01 · FY2003 · CA
Biochemical and Genetic Analysis of Notch Signaling
$336,088Raphael Kopan · Washington University · R01 · FY2007 · GM
Defining the Function and Regulation of Nuclear Envelope and Lamina Proteins in Myelopoiesis
$336,038Peter Charles Wigram Gaines · University Of Massachusetts Lowell · R15 · FY2015 · HL
Computational and Experimental Analysis of Vertebrate RNA Splicing
$336,000Christopher B Burge · Massachusetts Institute Of Technology · R01 · FY2009 · HG
Dissecting the role of germline genetic variation and viral exposures as determinants of hematological disease predisposition
$336,000Timothy J. Triche · Van Andel Research Institute · R03 · FY2024 · CA
Shwachman-Diamond Syndrome: Molecular Pathogenesis
$336,000Children'S Hospital Boston · R01 · FY2004 · HL
Attacking anthrax action by blocking receptor signaling
$335,965Dana-Farber Cancer Institute · R21 · FY2003 · AI
Acute Leukemia in the Elderly: Development of Novel, Targeted Therapeutics
$335,948Dan Longo · National Institute On Aging · ZIA · FY2009 · AG
NATURAL KILLER CELLS: ACQUISITION OF CD16 AND REGULATION OF NEGATIVE SIGNALING
$335,892Michael A Caligiuri · Ohio State University · P01 · FY2016 · CA
NATURAL KILLER CELLS: ACQUISITION OF CD16 AND REGULATION OF NEGATIVE SIGNALING
$335,892Michael A Caligiuri · Ohio State University · P01 · FY2015 · CA
Project 4: Targeting ATR in TP53-mutated MDS/AML
$335,882Daniel C Link · Washington University · P50 · FY2024 · CA
Hematologic Malignancies/BMT
$335,881Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2016 · CA
Project 2: Memory-like NK cell therapy for AML relapsed after allogeneic transplant
$335,880Todd A Fehniger · Washington University · P50 · FY2024 · CA
Project 1: Chimeric antigen receptor T-cell therapy for T cell malignancies
$335,880John F Dipersio · Washington University · P50 · FY2024 · CA